Biologics Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Feb 2021| TBR004E| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb; GlaxoSmithKline Plc.; AbbVie

Biologics Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider biologics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biologics market section of the report gives context. It compares the biologics market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biologics indicators comparison.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines

Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb; GlaxoSmithKline Plc.; AbbVie

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, biologics indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Historic Market Growth, Value ($ Billion)
  • Table 2 : Forecast Market Growth, Value ($ Billion)
  • Table 3 : Global Biologics Market, 2020, By Region, Value ($ Billion)
  • Table 4 : Global Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 5 : Global Biologics Market, Growth And Market Share Comparison, By Region
  • Table 6 : Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7 : Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8 : Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9 : Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10 : Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11 : Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 12 : Global Therapeutic Proteins Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 13 : Global Vaccines Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 14 : Biologics Market Size, Percentage Of GDP, 2015-2025, Global
  • Table 15 : Per Capita Average Biologics Market Expenditure, 2015-2025, Global
  • Table 16 : Asia-Pacific, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 17 : Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 18 : Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 19 : Per Capita Average Biologics Expenditure, 2015-2025, Asia-Pacific Countries
  • Table 20 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Asia-Pacific Countries
  • Table 21 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Asia-Pacific Countries
  • Table 22 : Asia-Pacific Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 23 : China Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 24 : China Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 25 : Australia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 26 : Australia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 27 : Hong Kong Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 28 : India Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 29 : India Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 30 : Indonesia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 31 : Indonesia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 32 : Japan Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 33 : Japan Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 34 : Malaysia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 35 : New Zealand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 36 : Philippines Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 37 : Singapore Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 38 : South Korea Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 39 : Thailand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 40 : Vietnam Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 41 : Western Europe, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 42 : Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 43 : Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 44 : Per Capita Average Biologics Expenditure, 2015-2025, Western Europe Countries
  • Table 45 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Western Europe Countries
  • Table 46 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Western Europe Countries
  • Table 47 : Western Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 48 : Austria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 49 : Belgium Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 50 : Denmark Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 51 : Finland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 52 : France Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 53 : France Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 54 : Germany Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 55 : Germany Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 56 : Ireland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 57 : Italy Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 58 : Netherlands Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 59 : Norway Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 60 : Portugal Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 61 : Spain Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 62 : Sweden Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 63 : Switzerland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 64 : UK Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 65 : UK Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 66 : Eastern Europe, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 67 : Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 68 : Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 69 : Per Capita Average Biologics Expenditure, 2015-2025, Eastern Europe Countries
  • Table 70 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Eastern Europe Countries
  • Table 71 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Eastern Europe Countries
  • Table 72 : Eastern Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 73 : Czech Republic Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 74 : Poland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 75 : Romania Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 76 : Russia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 77 : Russia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 78 : North America, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 79 : North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 80 : North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 81 : Per Capita Average Biologics Expenditure, 2015-2025, North America Countries
  • Table 82 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, North America Countries
  • Table 83 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, North America Countries
  • Table 84 : North America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 85 : Canada Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 86 : Mexico Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 87 : USA Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 88 : USA Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 89 : South America, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 90 : South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 91 : South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 92 : Per Capita Average Biologics Expenditure, 2015-2025, South America Countries
  • Table 93 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, South America Countries
  • Table 94 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, South America Countries
  • Table 95 : South America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 96 : Argentina Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 97 : Brazil Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 98 : Brazil Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 99 : Chile Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 100 : Colombia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 101 : Peru Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 102 : Venezuela Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 103 : Middle East, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 104 : Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 105 : Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 106 : Per Capita Average Biologics Expenditure, 2015-2025, Middle East Countries
  • Table 107 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Middle East Countries
  • Table 108 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Middle East Countries
  • Table 109 : Middle East Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 110 : Saudi Arabia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 111 : Israel Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 112 : Turkey Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 113 : UAE Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 114 : Africa, Biologics Market, 2020, By Country, Value ($ Billion)
  • Table 115 : Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 116 : Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 117 : Per Capita Average Biologics Expenditure, 2015-2025, Africa Countries
  • Table 118 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Africa Countries
  • Table 119 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Africa Countries
  • Table 120 : Africa Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 121 : Egypt Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 122 : Nigeria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 123 : South Africa Biologics Market2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 124 : Johnson & Johnson Financial Performance
  • Table 125 : F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 126 : Bristol-Myers Squibb Financial Performance
  • Table 127 : GlaxoSmithKline Plc. Financial Performance
  • Table 128 : AbbVie Financial Performance
  • Table 129 : Pharmaceuticals Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 130 : Global Pharmaceuticals Market, 2020, By Region, Value ($ Billion)
  • Table 131 : Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 132 : Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 133 : Global Biologics Market In 2025- Growth Countries
  • Table 134 : Global Biologics Market In 2025- Growth Segments
  • Table 135 : Global Biologics Market In 2025- Growth Strategies
  • Figure 1 : Historic Market Growth, Value ($ Billion)
  • Figure 2 : Forecast Market Growth, Value ($ Billion)
  • Figure 3 : Global Biologics Market, 2020, By Region, Value ($ Billion)
  • Figure 4 : Global Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 5 : Global Biologics Market, Growth And Market Share Comparison, By Region
  • Figure 6 : Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7 : Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8 : Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9 : Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10 : Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11 : Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 12 : Global Therapeutic Proteins Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 13 : Global Vaccines Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 14 : Biologics Market Size, Percentage Of GDP, 2015-2025, Global
  • Figure 15 : Per Capita Average Biologics Market Expenditure, 2015-2025, Global
  • Figure 16 : Asia-Pacific, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 17 : Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 18 : Asia-Pacific, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 19 : Per Capita Average Biologics Expenditure, 2015-2025, Asia-Pacific Countries
  • Figure 20 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Asia-Pacific Countries
  • Figure 21 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Asia-Pacific Countries
  • Figure 22 : Asia-Pacific Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 23 : China Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 24 : China Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 25 : Australia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 26 : Australia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 27 : Hong Kong Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 28 : India Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 29 : India Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 30 : Indonesia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 31 : Indonesia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 32 : Japan Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 33 : Japan Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 34 : Malaysia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 35 : New Zealand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 36 : Philippines Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 37 : Singapore Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 38 : South Korea Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 39 : Thailand Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 40 : Vietnam Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 41 : Western Europe, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 42 : Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 43 : Western Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 44 : Per Capita Average Biologics Expenditure, 2015-2025, Western Europe Countries
  • Figure 45 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Western Europe Countries
  • Figure 46 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Western Europe Countries
  • Figure 47 : Western Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 48 : Austria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 49 : Belgium Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 50 : Denmark Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 51 : Finland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 52 : France Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 53 : France Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 54 : Germany Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 55 : Germany Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 56 : Ireland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 57 : Italy Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 58 : Netherlands Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 59 : Norway Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 60 : Portugal Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 61 : Spain Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 62 : Sweden Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 63 : Switzerland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 64 : UK Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 65 : UK Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 66 : Eastern Europe, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 67 : Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 68 : Eastern Europe, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 69 : Per Capita Average Biologics Expenditure, 2015-2025, Eastern Europe Countries
  • Figure 70 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Eastern Europe Countries
  • Figure 71 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Eastern Europe Countries
  • Figure 72 : Eastern Europe Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 73 : Czech Republic Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 74 : Poland Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 75 : Romania Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 76 : Russia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 77 : Russia Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 78 : North America, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 79 : North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 80 : North America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 81 : Per Capita Average Biologics Expenditure, 2015-2025, North America Countries
  • Figure 82 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, North America Countries
  • Figure 83 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, North America Countries
  • Figure 84 : North America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 85 : Canada Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 86 : Mexico Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 87 : USA Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 88 : USA Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 89 : South America, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 90 : South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 91 : South America, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 92 : Per Capita Average Biologics Expenditure, 2015-2025, South America Countries
  • Figure 93 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, South America Countries
  • Figure 94 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, South America Countries
  • Figure 95 : South America Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 96 : Argentina Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 97 : Brazil Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 98 : Brazil Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 99 : Chile Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 100 : Colombia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 101 : Peru Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 102 : Venezuela Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 103 : Middle East, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 104 : Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 105 : Middle East, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 106 : Per Capita Average Biologics Expenditure, 2015-2025, Middle East Countries
  • Figure 107 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Middle East Countries
  • Figure 108 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Middle East Countries
  • Figure 109 : Middle East Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 110 : Saudi Arabia Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 111 : Israel Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 112 : Turkey Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 113 : UAE Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 114 : Africa, Biologics Market, 2020, By Country, Value ($ Billion)
  • Figure 115 : Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 116 : Africa, Biologics Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 117 : Per Capita Average Biologics Expenditure, 2015-2025, Africa Countries
  • Figure 118 : Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Africa Countries
  • Figure 119 : Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Africa Countries
  • Figure 120 : Africa Biologics Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 121 : Egypt Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 122 : Nigeria Biologics Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 123 : South Africa Biologics Market2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 124 : Johnson & Johnson Financial Performance
  • Figure 125 : F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 126 : Bristol-Myers Squibb Financial Performance
  • Figure 127 : GlaxoSmithKline Plc. Financial Performance
  • Figure 128 : AbbVie Financial Performance
  • Figure 129 : Pharmaceuticals Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Figure 130 : Global Pharmaceuticals Market, 2020, By Region, Value ($ Billion)
  • Figure 131 : Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 132 : Global Pharmaceuticals Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Figure 133 : Global Biologics Market In 2025- Growth Countries
  • Figure 134 : Global Biologics Market In 2025- Growth Segments
  • Figure 135 : Global Biologics Market In 2025- Growth Strategies

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report